Keikku
    About Us

    Meet the
    Team

    We are a team of entrepreneurs, engineers and physicians at the forefront of medical practice transformation and AI-augmented care.

    Jhonatan Bringas Dimitriades, MD

    Jhonatan Bringas Dimitriades, MD

    CEO and Co-founder

    Ex-Corsano Health | Ex-Lode | Advisor to Medscape. More than a decade of track record in the development and commercialization of medical technology. Previous companies have met exits or corporate deals.

    Diana van Stijn, MD PhD

    Diana van Stijn, MD PhD

    Chief Medical Officer and Co-founder

    Amsterdam UMC Hospital. Former Synchronized Swimming Pro Athlete. European and World competitive Swimmer. PhD in Pediatric Cardiology.

    Seamus Holohan

    Seamus Holohan

    COO and Co-founder

    Serial Entrepreneur. 6 companies founded. 4 exits | two exits to NASDAQ Trading companies.

    Rodrigo Alvez

    Rodrigo Alvez

    CTO and Co-founder

    Ex-Accenture. Serial Entrepreneur and founder of one of LATAM's biggest Telehealth companies.

    Toni Leinonen

    Toni Leinonen

    Head of Engineering and Founding Team member

    Serial Entrepreneur. Developed the Oura Ring. Founder of Haltian | Top IoT company in Europe. Raised around USD 100M in companies.

    Our Advisors

    Board of Advisors

    Craig LipsetAmir LahavFabia Tetteroo-BuenoGreg EnglehardtSuzanne Terheggen-LagroAustin ChiangCraig LipsetAmir LahavFabia Tetteroo-BuenoGreg EnglehardtSuzanne Terheggen-LagroAustin Chiang
    Our Journey

    Company Timeline

    2022

    Started in 2022

    Dr. Diana van Stijn, MD PhD and Jhonatan Bringas, MD decide it was time to start innovating in the realm of Sound as a biomarker.

    2023

    Raises USD 3.7M in 2023

    Lapsi Health raised USD 3.7M to finish the development of Keikku, its patented Digital Stethoscope powered by AI.

    2024

    FDA cleared and ISO in 2024

    Keikku was cleared as a Class II Medical Device by the Food and Drug Administration of the United States of America in 2024.

    2025

    Launch of Ambient capabilities in 2025

    Keikku launches its Ambient capabilities for Scribe, Vocal Biomarkers, Medical AI and its future multi-sensor approach. Keikku becomes the first contextual Medical Device, developed for AI delivery.

    Our Mission

    Breaking barriers in clinical AI

    We believe that every healthcare professional deserves tools that enhance their expertise, not replace it. Keikku combines cutting-edge AI with the timeless art of clinical examination to help clinicians deliver better care, faster.